APA

Hitz F., Zucca E., Pabst T., Fischer N., Cairoli A., Samaras P., Caspar C. B., Mach N., Krasniqi F., Schmidt A., Rothermundt C., Enoiu M., Eckhardt K., Berardi Vilei S., Rondeau S. & Mey U. (20170516). Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. : British journal of haematology.

Chicago

Hitz Felicitas, Zucca Emanuele, Pabst Thomas, Fischer Natalie, Cairoli Anne, Samaras Panagiotis, Caspar Clemens B, Mach Nicolas, Krasniqi Fatime, Schmidt Adrian, Rothermundt Christian, Enoiu Milica, Eckhardt Katrin, Berardi Vilei Simona, Rondeau Stephanie and Mey Ulrich. 20170516. Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. : British journal of haematology.

Harvard

Hitz F., Zucca E., Pabst T., Fischer N., Cairoli A., Samaras P., Caspar C. B., Mach N., Krasniqi F., Schmidt A., Rothermundt C., Enoiu M., Eckhardt K., Berardi Vilei S., Rondeau S. and Mey U. (20170516). Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. : British journal of haematology.

MLA

Hitz Felicitas, Zucca Emanuele, Pabst Thomas, Fischer Natalie, Cairoli Anne, Samaras Panagiotis, Caspar Clemens B, Mach Nicolas, Krasniqi Fatime, Schmidt Adrian, Rothermundt Christian, Enoiu Milica, Eckhardt Katrin, Berardi Vilei Simona, Rondeau Stephanie and Mey Ulrich. Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. : British journal of haematology. 20170516.